You need Flash player 8+ and JavaScript enabled to view this video.
視界のゆがみ、暗点、
ゆがみがある場合、急ぎましょう
眼科医に相談しましょう
症状を回復させる事ができるかもしれません
ＡＭＤの早期発見は健康な視力を保つために大切です
滲出性ＡＭＤに有効な抗血管新生療法を受けましょう
You need Flash player 8+ and JavaScript enabled to view this video.
You need Flash player 8+ and JavaScript enabled to view this video.
News
(English) Novartis Provides Update on Use and Safety of Beovu in Patients With Wet AMD (English) After the American Society of Retinal Specialists (ASRS) shared a note with its membership warning of vision-threatening cases of occlusive retinal vasculitis of wet AMD drug Beovu, Novartis...
Read More > (English) Following the Euopean Medicines Agency (EMA) human medicine’s committee recommendation in December, Beovu (brolucizumab) received formal approval by the European Commission … Sour...
Read More > (English) In latest calculations, researchers pooled data from 22 prevalence studies involving 55,323 people, aged, on average, between 60 and 81, and from four incidence studies across Europe … ...
Read More > (English) At EURETINA 2019 Congress, the Australia based company Ophthea reported data that OPT-302 reduced areas of neovascularization by 38% more and decreased scarring by 39% more, compared to Luce...
Read More > (English) Analysis of data from a Phase 2 study of abicipar pegol (Anti-VEGF DARPin®) in neovascular, or “wet,” age-related macular degeneration (AMD) showed positive results, leading to the deci...
Read More > (English) The presence of vitreous separation may play a role in ranibizumab therapy for neovascular age-related macular degeneration, according to a poster presented at the Association for Research i...
Read More >
